109 results
The objective of this trial is to compare time to gastrointestinal recovery after elective colorectal surgery between patients treated with a laxative versus patients treated with a placebo.
The primary objective of this study is to evaluate whether surgery of residual disease in patients iwth advanced GIST responding to Imatinib improves the progression free survival.The secondary objective is to correlate the pharmacokinetics of…
The aim of this randomized controlled multi-center study is to establish whether ETMI improves the detection early colorectal neoplasia compared to standard video endoscopy in a non-expert setting and is effective in differentiating neoplastic from…
Does ETMI improve the dysplasia in Barrett's esophagus?
Does oral simvastatin at standard doses alter BMP pathway signalling in colorectal cancer specimens in humans?
To establish the preferred treatment of AIN to prevent the development of severe anal neoplasia (persistent AIN III or anal carcinoma) in HIV+ MSM and HIV+ woman.
To investigate what CTC iodine tagging-only bowel preparation gives a high image quality and readability of the CTC together with a high patient acceptance.
The aim of this study is to determine whether chromoendoscopy, including polypectomy of all detected lesions, reduces the development of colorectal neoplasia in Lynch syndrome patients at follow-up endoscopy.
To demonstrate superiority of XP chemotherapy regimen plus cetuximab versus XP alone asfirst-line treatment for advanced gastric cancer in terms of PFS. To assess cetuximab + XP versus XP alone with respect to: OS; overall response; QoL; safety.
The primary objective is to evaluate the treatment effect of P*mAb plus FOLFIRI on overall survival (OS) and progression-free survival (PFS) compared to FOLFIRI alone as second line therapy for metastatic colorectal cancer.
Enteral Nutritional strategies compared to reduce postoperative ileus after major colorectal surgery
The main objective of this clinical survey is to improve the nutritional status of patients undergoing major rectal surgery, thereby aiming to reduce postoperative ileus using the Bengmark a self-migrating nasojejunal tube and early enteral…
The purpose of this study is to find answers for the following questions:1. Is BARRX ablation a good alternative to step-wise radical endoscopic resection for patients with a Barrett*s esophagus with high-grade dysplasia or early cancer in terms of…
The objective of this Phase III study is to evaluate the efficacy and safety of nintedanib in patients with mCRC after failure of previous treatment with standard chemotherapy and biological agents.
To compare the efficacy of P-SNN to EUS-CGN with regard to decreasing chronic malignant pain in patients with inoperable intra-abdominal malignancies.
To improve the local tumor control rate by escalating the radiation dose in definitive chemoradiotherapy for patients with locally irresectable or medically inoperable carcinoma of the esophagus or gastric junction without distant metastases (stage…
The primary objective of the study is to confirm that at least 1 or more doses of telotristat etiprate compared to placebo is effective in reducing the change from baseline in the number of daily bowel movements (BMs) averaged over the 12-week…
The aim of this study is to investigate the effects of early start versus delayed start of oral intake on postoperative recovery and pulmonary complications following esophagectomy. This is a non-inferiority trial.
The aim of this study is the efficacy of a simplified triple regimen at an energy setting of 12 J/cm2 instead of 2x2x15 J/cm2, without a cleaning phase in between, and its effect on the rate of stenosis and overall complications when using the Barrx…
The aim of this trial is to investigate which treatment option is superior in the treatment of anemia in patients undergoing surgery in terms of hemoglobin increase, postoperative morbidity, amount of bloodtransfusions needed, length of stay,…
This study investigates whether chemoradiotherapy (45 Gy in 5 weeks with daily cisplatin and capecitabine) after preoperative chemotherapy (3x ECC (epirubicin, cisplatin, capecitabine)) and adequate (D1+) surgery leads to improved survival in…